Tao Zhang

Tao Zhang

Auto-generated profile, based on publicly available information

Tao Zhang

School of Pharmacy Jiangxi University of Chinese Medicine Nanchang China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Food Chemistry
Verified
Journal Article
Closed access
YXYa-Ting Xie
Ya-Ting Xie
TBTing-Ting Bai
Ting-Ting Bai
TZTao Zhang
Tao Zhang
PZPeng Zheng
Peng Zheng
MHMin Huang
Min Huang
JZjinlian zhang
jinlian zhang

8 October 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YXYating Xie
Yating Xie
YLYing Liu
Ying Liu
PZPeng Zheng
Peng Zheng
TZTao Zhang
Tao Zhang
Xian-wen YEXian-wen YE
Xian-wen YE
JZjinlian zhang
jinlian zhang
Background. Major Depression Disorder (MDD) is a common mental disease that has become one of the worlds major medical diseases. Currently, the Fructus Aurantii (FA) has been widely used to treat depression. However, the active substance ingredients and potential mechanisms of the shell antidepression have not yet been clarified. Method. First, we used ultraperformance liquid chromatography-quadrupole/time-of-flight tandem mass (UPLC-QTOF-MS/MS) technology to identify the chemical composition of the FA. Then, it is predicted for active ingredients, pharmaceutical disease target screening by DiscoveryStudio 2016 (DS), Metascape, and other databases, PPI network diagram, and FC core pathway. Finally, the system network pharmacology results are verified by molecular contact verification. Results. Forty-six compounds in FA were identified, and twelve active ingredients were determined. Various database information, PPI network analysis of 41 intersections, and 20 core targets including DRD2, MTOR, FASP3, and PIK3P1 were integrated. Finally, the MDD treatment is indicated by molecular docking, and the most relevant potential signal pathway is the PI3K-Akt signaling pathway.

12 December 2023 in Biomedical Chromatography
Verified
Journal Article
Closed access
TZTao Zhang
Tao Zhang
YXYating Xie
Yating Xie
TLTao Li
Tao Li
YDYaling Deng
Yaling Deng
QWQuan Wan
Quan Wan
JZJinlian Zhang
Jinlian Zhang

22 June 2026 in Biomedical Chromatography
Verified
Journal Article
Closed access
YXYating Xie
Yating Xie
MLMinmin Liu
Minmin Liu
MLMinggui Liu
Minggui Liu
TZTao Zhang
Tao Zhang
CWChengfu Wang
Chengfu Wang
JZjinlian zhang
jinlian zhang